s20098 has been researched along with Chronic Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Białek, K; Bijak, M; Czarny, P; Gruca, P; Jóźwiak, P; Papp, M; Sliwinski, T; Synowiec, E; Szemraj, J; Wigner, P | 1 |
Almeida, OF; Alves, ND; Beckers, J; Bessa, JM; Correia, JS; Irmler, M; Korostynski, M; Machado-Santos, AR; Mateus-Pinheiro, A; Morais, M; Patrício, P; Piechota, M; Pinto, L; Sousa, N; Stoffel, R | 1 |
Antonen, EG; Kruchek, MM; Nikitina, MV | 1 |
Demirdaş, A; Nazıroğlu, M; Ünal, GÖ | 1 |
Goodwin, GM | 1 |
Gorwood, P; Le Strat, Y | 1 |
Kennedy, SH | 1 |
Dagyte, G; De Jager, T; Den Boer, JA; Gabriel, C; Luiten, PG; Mocaër, E; Van der Zee, EA | 1 |
Boyer, PA; Gruca, P; Mocaër, E; Papp, M | 1 |
2 review(s) available for s20098 and Chronic Disease
Article | Year |
---|---|
Agomelatine, an innovative pharmacological response to unmet needs.
Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Humans; Models, Animal; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2008 |
Treating each and every depressed patient.
Topics: Acetamides; Age Factors; Antidepressive Agents; Anxiety; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Female; Humans; Male; Patient Selection; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Severity of Illness Index; Sex Factors; Sleep; Time Factors; Treatment Outcome | 2008 |
7 other study(ies) available for s20098 and Chronic Disease
Article | Year |
---|---|
The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures.
Topics: Acetamides; Acetyltransferases; Animals; Brain; Chronic Disease; DNA Methylation; Gene Expression Regulation; Hypnotics and Sedatives; Indoleamine-Pyrrole 2,3,-Dioxygenase; Leukocytes, Mononuclear; Male; Rats; Rats, Wistar; Stress, Psychological; Tryptophan; Tryptophan Hydroxylase | 2020 |
Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus.
Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Dentate Gyrus; Depressive Disorder; Disease Models, Animal; Fluoxetine; Gene Expression; Imipramine; Male; Neurons; Random Allocation; Rats, Wistar; Stress, Psychological; Thiazepines; Uncertainty | 2015 |
[Clinical experience of the use of agomelatine in the treatment of patients with depression and chronic brain ischemia].
Topics: Acetamides; Adult; Anxiety; Brain Ischemia; Chronic Disease; Depression; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Initiation and Maintenance Disorders | 2015 |
Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.
Topics: Acetamides; Animals; Brain; Chronic Disease; Cytokines; Depression; Kidney; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Stress, Psychological | 2016 |
Major depression is sometimes described as the common cold of psychiatry.
Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Humans; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2008 |
Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain.
Topics: Acetamides; Animals; Antidepressive Agents; Brain Chemistry; Chronic Disease; Depressive Disorder; Disease Models, Animal; Male; Rats; Rats, Wistar; Stress, Psychological; Synapsins | 2011 |
Effect of agomelatine in the chronic mild stress model of depression in the rat.
Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Chronotherapy; Depression; Disease Models, Animal; Male; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Receptors, Serotonin; Stress, Physiological | 2003 |